In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

Reports of a flu-like virus called HMPV in China have sparked online misinformation, including posts with tens of thousands ...

The following is a summary of “Multiplex lateral flow test sensitivity and specificity in detecting influenza A, B and ...

COVID-19 appears to increase a person's risk of developing chronic fatigue syndrome. People who've caught COVID are nearly ...

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops significantly more frequently following SARS-CoV-2 ...

A U.S. study reveals a 4.5% prevalence of post-COVID-19 ME/CFS, shedding light on the link between SARS-CoV-2 infection and ...

China's National Medical Products Administration (NMPA) approved Innovent Biologics Inc.’s NDA for Dovbleron (taletrectinib), a next-generation ROS1 tyrosine kinase inhibitor (TKI), for treating ...

Biden chose a date nearly six years before the first cases of SARS-CoV-2 were identified, adding an unexpected layer of intrigue to the act of clemency.

The QuickFinder COVID-19/Flu Antigen Self-Test and the QuickFinder COVID-19/Flu Antigen Pro Test detect SARS-CoV-2, influenza A, and influenza B in swab specimens and provide results within 15 minutes ...

Scientists identify a signaling pathway that triggers muscle fatigue in response to nervous system inflammation or infections ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

CDC testing data for the same period reveals that 6.6 percent of COVID-19 tests came back positive, with Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin seeing the highest test positivity ...